New immunotherapeutic approaches: The use of cytokines to stimulate the immune system or to control the growth of malignant lymphoid cells

This publication has 11 references indexed in Scilit:

• Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2[ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors
  European Journal of Cancer and Clinical Oncology, 1989
• Murine Type II Fcγ Receptors and IgG-Binding Factors
  Published by S. Karger AG ,1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988
• Elevation of IgE-binding factors in serum of patients with B cell- derived chronic lymphocytic leukemia
  Blood, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• The Isotypic Circuit: Immunoglobulins, Fc Receptors and Immunoglobulin Binding Factors
  International Reviews of Immunology, 1987
• Biotherapy: The fourth modality of cancer treatment
  Journal of Cellular Physiology, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985